Ask AI
ProCE Banner Activity

CAR T-Cell Therapy Against NHL and CLL: Current and Emerging Clinical Trial Evidence

Slideset
Download this slideset for expert perspectives on current best practices and emerging strategies in the use of CAR T-cell therapy for patients with lymphomas and CLL.

Released: June 23, 2020

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Celgene

Legend Biotech USA Inc.

Faculty Disclosure

Primary Author

Michael R. Bishop, MD

Director, David and Etta Jonas Center for Cellular Therapy
Director, Transplantation and Cellular Therapy Program
Professor of Medicine
University of Chicago
Chicago, Illinois